Alyeska Investment Group, L.P. Surrozen, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.2 - $6.01 $200,376 - $547,390	-91,080 Reduced 22.96%	305,648 $920,000
Q4 2021 Feb 14, 2022	SELL	$6.0 - $9.92 $619,632 - $1.02 Million	-103,272 Reduced 20.65%	396,728 $2.56 Million
Q3 2021 Nov 15, 2021	BUY	$6.98 - $12.03 $3.49 Million - $6.02 Million	500,000 New	500,000 $2.97 Million

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $371M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.